{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T21:39:16Z","timestamp":1694554756627},"reference-count":0,"publisher":"Academy of Managed Care Pharmacy","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.18553\/jmcp.2006.12.5.371","type":"journal-article","created":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T09:30:10Z","timestamp":1456047010000},"page":"371-376","source":"Crossref","is-referenced-by-count":4,"title":["Effect of a Therapeutic Maximum Allowable Cost (MAC) Program on the Cost and Utilization of Proton Pump Inhibitors in an Employer-Sponsored Drug Plan in Canada"],"prefix":"10.18553","volume":"12","author":[{"given":"Vincent","family":"Mabasa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","container-title":["Journal of Managed Care Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,2,21]],"date-time":"2016-02-21T09:30:11Z","timestamp":1456047011000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2006.12.5.371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.18553\/jmcp.2006.12.5.371"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2006.12.5.371","relation":{},"ISSN":["1083-4087","1944-706X"],"issn-type":[{"value":"1083-4087","type":"print"},{"value":"1944-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}